Pro Pharma Introduces Information Exchange Hub: RxInfoX

CANOGA PARK, Calif. - April 27, 2016 - PRLog -- RxInfoX joins Pro Pharma's Pharmacy Benefit News (PBN) as one of the contributions to the health care news cycle.  The exchange of ideas, questions, viewpoints, and analyses are at the heart of a rational approach to news.

RxInfoX grew out of Pro Pharma's need to centralize the collection of current, timely, and relevant information.  This internal need is also applicable to a much broader audience of the general health care industry.

RxInfoX provides up-to-the minute news capsules relating to general and health care stock indices, health news, pharmacy manufacturing news, specialty medicine, and health care analytics, to name a few.  RxInfoX is updated throughout the day, every day, as relevant stories hit the news media.  Pro Pharma is continually monitoring these new updates for relevancy and importance to the general healthcare population.

In the near future, Pro Pharma will look to expand the RxInfoX offerings relating to the basic science of disease and drug impact as well as links to articles that explain the complicated pathophysiology and pharmacology underlying today's health care.  Similar to Pharmacy Benefit News, we will endeavor to comment on major topics which will provide some perspectives and potentially to stimulate conversations.

RxInfoX is dynamic and will be regularly expanded and improved.

Look to RxInfoX for a quick and objective daily read at http://www.propharmaconsultants.com/RxInfoX.html

We encourage you to share your thoughts, questions, and suggestions for improvement to assist us in providing valuable information for all of our readers!

About PRO PHARMA

PRO PHARMA is a multi-service, woman owned, privately held consulting firm offering a vast portfolio of services to public and private entities including self-insured employers, Taft Hartley Trusts and unions, public employers, for-profit hospitals and integrated health networks, health care insurance companies, worker's compensation insurers, small-to-medium sized HMO's, and physician groups.

As a primary service to plan sponsors for achieving below trend results, PRO PHARMA provides an integrated program of administrative process improvements, clinical quality oversight, and provider/member education.

PRO PHARMA's Consulting services are grounded in the use of data and the communication of that information to define benefit trends, drivers and other analytical indicators.   PRO PHARMA markets Biotech Modeling™, Invoice Screening™, Quality Management Program™, and Treatment Calendar™. The Company directly markets its products in the U.S. and collaborates with partners to reach international markets.

For more information about PRO PHARMA, please visit http://www.propharmaconsultants.com.